Valuation: Edwards Lifesciences Corporation

Market Cap 54.8B 48B 44.21B 41.04B 77.93B 5,228B 78.98B 529B 206B 2,566B 206B 201B 8,897B P/E 2026 *
33.9x
P/E 2027 * 29.1x
Enterprise Value 51.32B 44.95B 41.4B 38.43B 72.97B 4,896B 73.96B 496B 193B 2,403B 193B 189B 8,332B EV / Sales 2026 *
7.61x
EV / Sales 2027 * 6.71x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week+4.39%
Current month+5.22%
1 month+10.73%
3 months+17.23%
6 months+10.87%
Current year+11.65%
1 week 90.28
Extreme 90.28
95.57
1 month 83.17
Extreme 83.17
95.57
Current year 74.66
Extreme 74.66
95.57
1 year 72.3
Extreme 72.3
95.57
3 years 58.93
Extreme 58.93
96.12
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
06-30Fiscal year

Executive/Senior Manager

1,857 0.0003%
06-17Sell

Chief Executive Officer

-523 0.0001%
05-29Sell

Controller/Auditor

-568 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+4.39%+23.95%+5.22% 54.8B
-1.12%+2.21%+20.56%+0.05% 192B
+1.60%+6.62%-20.50%+31.10% 153B
-2.18%+0.44%-4.71%-17.40% 137B
-1.20%+2.58%-57.25%-15.66% 66.29B
+1.25%+2.98%-24.42%-28.96% 44.44B
-0.11%+2.72%+8.19%+42.98% 37.2B
-0.07%-1.68%+7.60%+10.28% 36.89B
+4.18%+10.06%-15.01%+1.58% 31.5B
-1.11%-0.32%-14.76%-18.05% 29.5B
Average +0.21%+2.68%-7.64%+1.11% 78.33B
Weighted average by Cap. -0.20%+3.15%-4.76%+2.36%

Financials

2026 *2027 *
Net sales 6.75B 5.91B 5.44B 5.05B 9.59B 644B 9.72B 65.16B 25.36B 316B 25.34B 24.79B 1,095B 7.41B 6.49B 5.98B 5.55B 10.54B 707B 10.68B 71.56B 27.85B 347B 27.83B 27.22B 1,203B
Net income 1.62B 1.42B 1.31B 1.22B 2.31B 155B 2.34B 15.68B 6.1B 76.05B 6.1B 5.97B 264B 1.89B 1.66B 1.53B 1.42B 2.69B 180B 2.73B 18.26B 7.11B 88.55B 7.1B 6.95B 307B
Net Debt -3.48B -3.05B -2.81B -2.61B -4.95B -332B -5.02B -33.63B -13.09B -163B -13.08B -12.79B -565B -5.07B -4.44B -4.09B -3.8B -7.21B -484B -7.31B -48.98B -19.06B -238B -19.05B -18.63B -823B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
06/07/26 US$95.18 +0.86% 3,958,057
02/07/26 US$94.37 +2.59% 3,206,400
01/07/26 US$91.99 +1.69% 4,284,007
30/06/26 US$90.46 -0.79% 3,627,318
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
95.18USD
Average target price
97.31USD
Spread / Average Target
+2.24%

Quarterly revenue - Rate of surprise